Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR

ACORDA THERAPEUTICS INC (ACOR)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/05/2017 12/06/2017 12/07/2017 12/08/2017 12/11/2017 Date
20.45(c) 20.35(c) 20.75(c) 21.05(c) 20.4(c) Last
506 167 372 100 754 316 504 441 660 768 Volume
-1.68% -0.49% +1.97% +1.45% -3.09% Change
More quotes
Financials ($)
Sales 2017 574 M
EBIT 2017 -25,5 M
Net income 2017 -25,5 M
Debt 2017 150 M
Yield 2017 -
Sales 2018 405 M
EBIT 2018 29,0 M
Net income 2018 -7,18 M
Debt 2018 118 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 1,92x
EV / Sales2018 2,65x
Capitalization 954 M
More Financials
Company
Acorda Therapeutics, Inc. develops and markets therapeutic products for nervous system disorders.The company's two main products are Ampyra and Zanaflex Capsules.The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short... 
More about the company
Surperformance© ratings of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACORDA THERAPEUTICS INC
08:01a THE KLEIN LAW FIRM : Reminds Investors of a Class Action Filed on Behalf of Acor..
12/11 Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from ..
12/11 ACOR The Law Offices of Vincent Wong Reminds Investors of a Class Action Invo..
12/10 ACORDA THERAPEUTICS INC : Pomerantz Law Firm Reminds Shareholders with Losses on..
12/07 Levi & Korsinsky, LLP Reminds Shareholders of Acorda Therapeutics, Inc. of Co..
12/07 ACORDA THERAPEUTICS : The Klein Law Firm Notifies Investors of an Investigation ..
12/07 ACORDA THERAPEUTICS,INC. (NASDAQ : ACOR) Files An 8-K Other Events
12/07 ACORDA THERAPEUTICS INC : Bronstein, Gewirtz & Grossman, LLC Reminds Investors o..
12/07 ACORDA THERAPEUTICS INC : Other Events, Financial Statements and Exhibits (form ..
12/07 ACORDA THERAPEUTICS : Resubmits New Drug Application for INBRIJA™ (CVT-301..
More news
Sector news : Bio Therapeutic Drugs
12:46p Sanofi investors hungry for drug progress and deal news
10:43a M&A dominates Europe share trading as oil leads gains
12/09 Tax-loss selling to pressure 2017's losers in December
11/30 GENMAB : and J&J 'love' partnership as some ponder takeover
11/27 MERCK AND : As Brexit looms, UK pitches new industry plan, wins support from Mer..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
12/08 YOUR DAILY PHARMA SCOOP : Geron Update, Acorda Resubmits NDA, Sage Rallies
12/07 Acorda refiles U.S. marketing application for Parkinson's med Inbrija; shares..
12/07 YOUR DAILY PHARMA SCOOP : Gilead's Potential, Celgene CAR-T Candidate, Cellectar..
11/29 YOUR DAILY PHARMA SCOOP : Omeros If And Buts, Egalet's Oxycodone Success, Auris ..
11/28 Premarket analyst action - healthcare
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Technical analysis trends ACORDA THERAPEUTICS INC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 21,0 $
Spread / Average Target 2,9%
EPS Revisions
Managers
NameTitle
Ronald Cohen President, Chief Executive Officer & Director
Andrew R. Blight Chief Scientific Officer
Richard P. Batycky Chief Technology Officer
Burkhard Blank Chief Medical Officer
Sandra Panem Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ACORDA THERAPEUTICS INC10.37%954
GILEAD SCIENCES1.55%99 094
REGENERON PHARMACEUTICALS1.78%40 969
VERTEX PHARMACEUTICALS88.38%35 831
GENMAB1.79%11 452
BLUEBIRD BIO INC172.12%9 249